Advertisement

Topics

Medtech Company Endotronix Snags $45 Million in Series D Funding

20:00 EDT 13 Sep 2018 | BioSpace

Lisle, Ill.-based medtech company Endotronix, Inc. secured $45 million in a Series D financing round. The funds will be used to support the commercialization of its Cordella Heart Failure System and support clinical development of the company’s pulmonary artery sensor.

Original Article: Medtech Company Endotronix Snags $45 Million in Series D Funding

NEXT ARTICLE

More From BioPortfolio on "Medtech Company Endotronix Snags $45 Million in Series D Funding"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...